Get the Stockscreener App
6.2926
2.34%
-0.1074
Lensar Inc stock is traded at $6.2926, with a volume of 32,750.
It is down -2.34% in the last 24 hours and up +11.61% over the past month.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.
See More
Previous Close:
$6.40
Open:
$6.43
24h Volume:
32,750
Relative Volume:
0.35
Market Cap:
$77.50M
Revenue:
$57.70M
Net Income/Loss:
$11.98M
P/E Ratio:
-10.95
EPS:
-0.5746
Net Cash Flow:
$-12.24M
1W Performance:
+9.27%
1M Performance:
+11.61%
6M Performance:
-45.41%
1Y Performance:
-52.51%
1-Day Range:
$6.03
$6.44
1-Week Range:
$5.62
$6.44
52-Week Range:
$5.06
$13.43
Lensar Inc Stock (LNSR) Company Profile
Name
Lensar Inc
Sector
Industry
Phone
888-536-7271
Address
2800 DISCOVERY DRIVE, ORLANDO
Compare LNSR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNSR
Lensar Inc
|
6.31 | 70.13M | 57.70M | 11.98M | -12.24M | -0.5746 |
ABT
Abbott Laboratories
|
95.79 | 158.05B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
326.48 | 120.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.65 | 100.14B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.07 | 63.44B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
95.43 | 52.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Lensar Inc Stock (LNSR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-01-26 | Upgrade | Lake Street | Hold → Buy |
| Mar-18-26 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-24-21 | Initiated | SVB Leerink | Outperform |
Lensar Inc Stock (LNSR) Latest News
(LNSR) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Price to sales forward of LENSAR, Inc. – NASDAQ:LNSR - TradingView
LENSAR, Inc.(NasdaqCM: LNSR) dropped from Russell 2000 Dynamic Index - marketscreener.com
LENSAR, Inc.(NasdaqCM: LNSR) dropped from Russell 3000E Index - marketscreener.com
LENSAR, Inc.(NasdaqCM: LNSR) dropped from Russell Small Cap Completeness Index - marketscreener.com
LENSAR, Inc.(NasdaqCM: LNSR) dropped from Russell 2500 Index - marketscreener.com
LENSAR, Inc.(NasdaqCM: LNSR) dropped from Russell 3000 Index - marketscreener.com
LENSAR, Inc.(NasdaqCM: LNSR) added to Russell Microcap Value Benchmark Index - marketscreener.com
LENSAR, Inc.(NasdaqCM: LNSR) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Lensar Stock Slumps After Hours On Ending Merger Deal With Alcon Over FTC Pushback - Stocktwits
LENSAR, Inc.(NasdaqCM: LNSR) dropped from Russell 3000 Growth Benchmark - marketscreener.com
LENSAR Inc Actuals & Estimates (NASDAQ:LNSR) - TradingView
LNSR Forecast — Price Target — Prediction for 2027 - TradingView
[ARS] LENSAR, Inc. SEC Filing - Stock Titan
LENSAR (NASDAQ: LNSR) schedules 2026 virtual meeting, say-on-pay and auditor vote - Stock Titan
LENSAR sets up next earnings date, shares trade in a tight Nasdaq range - AD HOC NEWS
LENSAR Inc (LNSR) Valuation: PE, PB & Fair Value Analysis - TradingKey
LENSAR Inc (LNSR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
(LNSR) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
LENSAR StockWeekly review in a volatile small-cap medtech sector - AD HOC NEWS
LENSAR INC (LNSR) Stock Chart - ChartMill
LENSAR Inc (LNSR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
LENSAR Inc (LNSR) Institutional Confidence - TradingKey
LENSAR Inc (LNSR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
LENSAR Inc (LNSR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
LENSAR Inc (LNSR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
LENSAR Inc (LNSR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
LENSAR Inc (LNSR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LENSAR (LNSR) Consolidates Near Support as Traders Eye Resistance at $6.11Box Spread - newsline.com
LENSAR Q1 earnings call highlights - MSN
(LNSR) Risk Channels and Responsive Allocation - Stock Traders Daily
LNSR Technical Analysis & ETF Price Forecast - Intellectia AI
LENSAR (LNSR) director Ellis granted 17,421 RSUs and reports holdings - Stock Titan
Lensar (LNSR) director receives 17,421 RSUs, reports 1.1M+ indirect shares - Stock Titan
LENSAR (LNSR) grants 13,066 RSUs to principal accounting officer - Stock Titan
LENSAR (LNSR) COO granted 34,843 RSUs in four-year vesting award - Stock Titan
LENSAR (LNSR) CEO receives 130,662 RSUs vesting over four years - Stock Titan
LENSAR (LNSR) director Aimee Weisner receives 17,421 RSUs as annual equity grant - Stock Titan
LENSAR (LNSR) director awarded 17,421 RSUs as annual stock compensation - Stock Titan
LENSAR (LNSR) director Gary Winer receives 17,421 RSU equity award - Stock Titan
LENSAR (LNSR) director receives 17,421 RSUs as annual equity award - Stock Titan
LENSAR, Inc. (LNSR) director receives 17,421 RSU equity grant - Stock Titan
LENSAR (LNSR) Interim CFO Michael A. Rossi files initial SEC Form 3 - Stock Titan
How The LENSAR (LNSR) Story Is Shifting After The Failed Deal And New $10 Target - Yahoo Finance
Lensar Inc. Earnings Call Balances Recovery And Risk - The Globe and Mail
LENSAR Inc stock (US52633C1071): Q1 recurring revenue rose 9% - AD HOC NEWS
Lensar (LNSR) Q1 2026 Earnings Transcript - AOL.com
Lensar (LNSR) Q4 2025 Earnings Transcript - AOL.com
Lensar Reports First Quarter Fiscal 2026 Results; Management Highlights Strategic ProgressRevenue Inflection Point - newsline.com
Lensar (LNSR) Releases Q1 2026 Earnings Transcript: Key Insights for InvestorsGuidance Accuracy Score - The Legal Advocate
LENSAR Appoints Interim CFO, Accelerates Governance Timeline - The Globe and Mail
Lensar Inc Stock (LNSR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lensar Inc Stock (LNSR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| STAAB THOMAS R II | Chief Financial Officer |
Mar 19 '26 |
Option Exercise |
2.65 |
5,500 |
14,575 |
175,959 |
3.43%
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):